- Home
- FET vs ADCT Comparison
FET vs ADCT Comparison
Compare FET & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FET
- ADCT
- Stock Information
- Founded
- FET 2005
- ADCT 2011
- Country
- FET United States
- ADCT Switzerland
- Employees
- FET N/A
- ADCT N/A
- Industry
- FET Metal Fabrications
- ADCT Biotechnology: Pharmaceutical Preparations
- Sector
- FET Industrials
- ADCT Health Care
- Exchange
- FET Nasdaq
- ADCT Nasdaq
- Market Cap
- FET 234.5M
- ADCT 224.3M
- IPO Year
- FET 2012
- ADCT 2020
- Fundamental
- Price
- FET $19.45
- ADCT $1.72
- Analyst Decision
- FET
- ADCT Strong Buy
- Analyst Count
- FET 0
- ADCT 5
- Target Price
- FET N/A
- ADCT $8.00
- AVG Volume (30 Days)
- FET 70.1K
- ADCT 709.5K
- Earning Date
- FET 02-18-2025
- ADCT 03-12-2025
- Dividend Yield
- FET N/A
- ADCT N/A
- EPS Growth
- FET N/A
- ADCT N/A
- EPS
- FET N/A
- ADCT N/A
- Revenue
- FET $800,612,000.00
- ADCT $70,717,000.00
- Revenue This Year
- FET $11.71
- ADCT $6.81
- Revenue Next Year
- FET $0.85
- ADCT $11.23
- P/E Ratio
- FET N/A
- ADCT N/A
- Revenue Growth
- FET 7.56
- ADCT N/A
- 52 Week Low
- FET $12.83
- ADCT $1.68
- 52 Week High
- FET $21.51
- ADCT $6.04
- Technical
- Relative Strength Index (RSI)
- FET 70.32
- ADCT 40.45
- Support Level
- FET $18.96
- ADCT $1.68
- Resistance Level
- FET $19.98
- ADCT $1.87
- Average True Range (ATR)
- FET 0.75
- ADCT 0.13
- MACD
- FET 0.31
- ADCT 0.00
- Stochastic Oscillator
- FET 83.77
- ADCT 8.65
About FET Forum Energy Technologies Inc.
Forum Energy Technologies Inc is a products company, serving the oil, natural gas, industrial and renewable energy industries. The company designs, manufactures, and distributes products and engages in aftermarket parts supply and services that complement its product offering. Its products include engineered capital equipment, as well as products that are consumed in the drilling, well construction, production, and transportation of oil and natural gas. It operates in three reporting segments, namely drilling and downhole which is also its key revenue generating segment, completions, and production. Revenue largely comes from consumable products and activity-based equipment. Consumable products include valves, centrifugal pumps, mud pump fluid end components, rig sensors among others.
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.